 April 27, 2022
Perfluoroalkyl
and polyfluoroalkyl substances (PFASs) are ubiquitous synthetic
compounds found in many products, including Teflon, water-resistant
materials, paints, and firefighting foams. PFASs are commonly detected
in biomonitoring studies in everything from air, water and soil to fish,
animals, and human blood. Environmental and health agencies in Europe,
the U.S., and Australia have identified PFASs as potential carcinogens
and have linked them to several other adverse health effects. [Read More]
|
 April 20, 2022
Hemolytic
disease of the newborn (HDN) is a serious disease associated with
significant morbidity and mortality. HDN occurs when maternal antibodies
attack fetal red blood cells (RBCs) causing hemolysis; alloimmunization
can occur to more than 50 antigens, but the most severe forms of HDN
are associated with RhD, Rhc and K antigens. First-line treatments
include phototherapy to help break down excess bilirubin and exchange
transfusion to physically remove bilirubin. [Read More]
|
 April 12, 2022
The
use of COVID-19 convalescent plasma (CCP) has been highly controversial
since the beginning of the pandemic. With the Food and Drug
Administration’s approval and establishment of the Expanded Access
Program, over 100,000 units of CCP were distributed to U.S. hospitals
every month during the winter of 2020-2021 despite limited data on its
efficacy. [Read More]
|
No comments:
Post a Comment